BioMedical SIG #4

BioMedical SIG #4

Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success.

Book Your Place

This event has now expired

Fourth webinar in the series: From research and innovation to development: how to plan and execute translational projects in life sciences, this edition looks more closely at IP protection strategies for translational research.

It focuses on intellectual property (IP) and spin-out strategies in the human healthcare sector. A well-designed IP strategy, tailored to the type of innovation, is crucial for the long-term success of university spin-outs.

Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements. They’ll share insights on the essential components of an IP strategy for the healthcare sector and discuss how these components vary based on the type of innovation—whether in biotech, pharma, or digital health—and the intended business model.

Booking Options

  • Are you an ASTP Member?

  • By proceeding with this booking, you are agreeing to allow ASTP to use your image solely for promotional and educational purposes.

Testimonials

testimonial

Working and Learning with old and new friends – best way to do it!

Sara Matt-Leubner

University of Innsbruck, Austria

testimonial

Great atmosphere to learn and to share experiences.

Maria Ruiz Novales

Interface-Enterprises - University of Liege, Belgium

testimonial

A lot of fruitful discussions with experienced peers. Very helpful sessions.

Sara Matt-Leubner

University of Innsbruck, Austria

testimonial

Most experienced technology transfer crew in the Europe.

Krzysztof Maternicki

Jan Dlugosz University, Poland

testimonial

The software course has provided invaluable information as our TTO expands to take on software cases.

Tom Withnell

University of Vienna, Austria